News

2008-09-12 Read-Gene is planing to enter New Connect Stock Exchange

Read-Gene, a Polish biotech company, established by a group of scientists from Pomeranian Medical Academy, decided to enter New Connect. Their valuable Intellectual Property and R&D capability make the company a potential New Connect star, as it is claimed by Ludwik Sobolewski.

Read-Gene is planning to enter the global market with their patented genetic tests determining the genetic predisposition for cancer development. Other interesting asset of the company is their unique database containing precisely defined genetic profiles of around 2 000 000 personal records. This database is a valuable source of information for clinical research. Read-Gene is also testing their novel food supplement, which could decrease the risk of developing tumors in people, who have this risk enhanced.
M.Mackowski